Preliminary results by the Covid-ip project identified two prominent immunological signatures in the blood of Covid-19 patients that could be used to identify the patients most likely to do worse and require additional treatment.
Preliminary results by the Covid-ip project identified two prominent immunological signatures in the blood of Covid-19 patients that could be used to identify the patients most likely to do worse and require additional treatment.